Skip To Main Content
Afsal Nalarakettil on Muck Rack

Afsal Nalarakettil

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Afsal

Contact Afsal, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Foslevodopa–Foscarbidopa subcutaneous infusion in Parkinson’s disease: a cross-cultural/cross-racial international multicentre comparative tolerability study (CRIM-FOS study)

|
By Vinod Metta, Karolina Poplawska-Domaszewicz, Hasna Hussain, Mohamed Elmahdy, Per Odin, Kallol Ray Chaudhuri, Ola Brek, Afsal Nalarakettil, Therese Masagnay, Clarissa Sangilan
| Nature Verified
Abstract Advanced Parkinson’s disease (APD) often presents challenges such as irregular gastric absorption and delayed gastric emptying, leading to significant and unpredictable fluctuations in both motor and non-motor symptoms. Our study is a real-world, open-label study of the tolerability and efficacy of subcutaneous infusion of Foslevodopa/Foscarbidopa (FL/FC) focus on comparing White Caucasian patients and non-White patient cohorts.
Open in Who Shared Issue with article?
See all 1 articles